Prostate cancer research may be faster with PSA endpoints
18th Apr 2006, 21:33 GMT
A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival. Researchers looking to speed up the process of clinical trials have suggested that these biomarkers could be used to measure treatment efficacy.
Prostate cancer research may be faster with PSA endpoints related news:
- Prostate Cancer Research May Be Faster With PSA Endpoints — ScienceDaily Headlines
- A Better Way to Gauge Prostate Cancer Risk? (HealthDay) — Yahoo! Health: Health News
- New predictive model to assess individual's risk of prostate cancer — EurekAlert! - Mathematics and Statistics
- Other highlights in the April 19 JNCI — EurekAlert! - Breaking News
- Update on Prostate Cancer Chemoprevention — Medscape Internal Medicine Headlines
- Cutting-Edge Cancer Treatment Center Improves Health of Thousands — Adventist News Network
- Prostate Cancer: Better Way to Gauge Risk? — MedicineNet Mens Health General
- Dennis Rodman: the bad boy of cancer charity — The Cancer Blog
- Scientists Reveal First Ever Complete Structure Of Crucial Anti-Cancer Drug Target — Medical News Today RSS/XML Feed
- Delayed Surgery In Well-Selected Prostate Cancer Patients Not Associated With Worse Outcome — Medical News Today RSS/XML Feed
Latest news from EurekAlert! - Social and Behavioral Science:
- New research strives to understand how antidepressants may be associated with suicidality
- ALTRAN unveils its energy efficiency concepts solutions
- Obese kidney transplant patients twice as likely to die in the first year or suffer organ failure
- Pharmacy care program helps elderly patients take all their medications
- Global Environmental Change scientists seek to improve links with policy and development agendas
- Venus Express wins Popular Science's 'Best of What's New' award
- Psychoanalysts to convene Winter 2007 Meeting, Jan. 17-21, 2007
- Higher level of certain fatty acid associated with lower dementia risk
- Depression, not antidepressants, increases mortality risks in heart failure
- Counseling Alzheimer's caregivers postpones the nursing home